AGP Executive Report
Last update: 10 hours agoHealthcare AI & Policy: The Netherlands still lacks a dedicated health AI strategy, and hospital leaders warn the real problem is uncertainty over safety, legal responsibility, and clinical validation. Medical Devices in Europe: Caretaker Medical’s VitalStream® wireless multimodal hemodynamic monitoring platform has received CE Mark approval, expanding continuous monitoring options across invasive and non-invasive setups. Kidney Care Breakthrough: Late Phase III FIND-CKD results show finerenone slows kidney function decline and lowers cardiovascular-kidney risk in non-diabetic chronic kidney disease. EU Migration & Health Systems Pressure: EU ministers reviewed rollout of the asylum and migration pact and Eurodac ahead of its 12 June start, with faster procedures and shared responsibility aimed at reducing pressure on member states. Dutch Reporting Spotlight: A Dutch investigation into children in Gaza won a major European press prize, built from medical records and interviews with clinicians across multiple hospitals and clinics. Pharma & Trials: Azafaros published Phase 2 RAINBOW study data for nizubaglustat in GM2 gangliosidosis and Niemann-Pick disease, reporting safety and encouraging efficacy signals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.